FASCIOLIASIS

Clinical trials for FASCIOLIASIS explained in plain language.

Never miss a new study

Get alerted when new FASCIOLIASIS trials appear

Sign up with your email to follow new studies for FASCIOLIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Completed 1

Could one dose beat two? new trial tests simpler treatment for parasitic liver disease

Disease control Not yet recruiting

This study tests whether one or two doses of the drug oxfendazole can cure chronic fascioliasis (a liver infection caused by a parasite) as well as the standard two-dose treatment with triclabendazole. About 336 adults in Peru will be randomly assigned to one of three groups. Res…

Matched conditions: FASCIOLIASIS

Phase: PHASE2 • Sponsor: Universidad Peruana Cayetano Heredia • Aim: Disease control

Last updated Jun 27, 2026 13:01 UTC

FASCIOLIASIS

Get alerted when new FASCIOLIASIS trials appear

Could one dose beat two? new trial tests simpler treatment for parasitic liver disease